Modern aspects of managing patients with inflammatory diseases of the external and middle ear

Author:

Vladimirova T. Yu.1ORCID,Martynova A. B.1ORCID

Affiliation:

1. Samara State Medical University

Abstract

Introduction. The article considers approaches to the management of patients with inflammatory diseases of the middle ear at the outpatient and hospital stages.Aim. To substantiate the guidelines for endaural treatment of inflammatory ear diseases with Anauran® ear drops from the perspective of the best clinical efficiency.Materials and methods. A total of 53 patients (106 ears) were examined, of which 21 patients were diagnosed with otitis externa diffusa (24 ears), 23 patients (25 ears) with acute catarrhal otitis media and 9 patients (9 ears) with epitympanitis in remission, who underwent type 1 tympanoplasty. The efficacy of Anauran® as part of combination treatment was compared in the following age groups: in patients over 18 years old (mean age 39.2 ± 11.1 years) and in children (mean age 9.8 ± 6.5 years).Results and discussion. Absolute scores determined in assessing ear pain in the group of patients with acute otitis externa diffusa ranged from 3 to 9 scores; in the group with acute catarrhal otitis media – from 3 to 8 scores, in patients after tympanoplasty – from 2 to 8 scores. There was some difference in the assessment of the ear pain severity between children and patients over 18 years of age. The most short-term changes in ear pain occurred in children with acute otitis externa diffusa and acute catarrhal otitis media. As a result, the vast majority of patients showed a clinical effect on Day 7, which consisted in the recovery of the otoscopic status, a decrease in complaints by up to 96.3% in adults and up to 96.1% in children. The use of Anauran® ear drops in the complex management of patients with inflammatory diseases of the middle ear reduces the duration of treatment and eliminates problems with secondary bacterial infections in the postoperative period.Conclusions. The findings support the high efficiency of Anauran® in the combination therapeutic treatment of inflammatory processes of the outer and middle ear.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference16 articles.

1. Nikitin K.A., Arustamyan I.G., Bolozneva E.V. Local etiotropic treatment for acute external and otitis media. Meditsinskiy Sovet. 2013;(7):22–25. (In Russ.) https://doi.org/10.21518/2079-701X-2013-7-22-25.

2. Nikiforova G.N., Svistushkin V.M., Dedova M.G. Possibilities of local therapy of infectious and inflammatory diseases of the upper respiratory tract. RMJ. 2015;(6):346. (In Russ.) Available at: https://www.rmj.ru/archive/otorinolaringologiya_8/.

3. Turovsky A.B., Kryukov A.I. Acute inflammation of the outer and middle ear. Consilium Medicum. 2000;8(2):323–325. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/91296.

4. Kosyakov S.Ya. Inflammatory diseases of the external auditory canal and methods of their treatment. Vestnik Oto-Rino-Laringologii. 2011;(1):81–85. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnikotorinolaringologii/2011/1/.

5. Morozova S.V., Karapetyan L.S. An integrated approach to the treatment of patients with otitis externa. Farmateka.2017;6(339):7–11. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/34740.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3